• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.化学预防和疫苗接种在预防脑膜炎球菌病病例家庭接触者后续脑膜炎球菌病病例中的作用:一项系统评价
Epidemiol Infect. 2015 Aug;143(11):2259-68. doi: 10.1017/S0950268815000849. Epub 2015 Apr 28.
2
Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.病例出现后抗生素预防脑膜炎球菌病的有效性:系统评价
BMJ. 2004 Jun 5;328(7452):1339. doi: 10.1136/bmj.328.7452.1339.
3
Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.在出现一例脑膜炎球菌病病例后,除化学预防外对家庭接触者进行疫苗接种的有效性:一项系统评价
Epidemiol Infect. 2008 Nov;136(11):1441-7. doi: 10.1017/S0950268808000770. Epub 2008 Jun 18.
4
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.用于预防A群脑膜炎球菌性脑膜炎的多糖疫苗。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD001093. doi: 10.1002/14651858.CD001093.pub2.
5
Antibiotics for preventing meningococcal infections.预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004785. doi: 10.1002/14651858.CD004785.pub3.
6
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004785. doi: 10.1002/14651858.CD004785.pub2.
7
What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease?与脑膜炎球菌病病例就读于同一幼儿园、学校或学院的儿童或学生,给予化学预防的依据是什么?
Epidemiol Infect. 2011 Nov;139(11):1645-55. doi: 10.1017/S0950268811001439. Epub 2011 Aug 11.
8
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5.
9
Vaccines for preventing infections in adults with solid tumours.用于预防实体瘤成年患者感染的疫苗。
Cochrane Database Syst Rev. 2025 Apr 16;4(4):CD015551. doi: 10.1002/14651858.CD015551.pub2.
10
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.

引用本文的文献

1
Sequelae following an epidemic of meningococcal meningitis in Niger in 2022.2022年尼日尔脑膜炎球菌性脑膜炎疫情后的后遗症。
PLoS One. 2025 May 22;20(5):e0323223. doi: 10.1371/journal.pone.0323223. eCollection 2025.
2
Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.尼日尔脑膜炎球菌性脑膜炎疫情分析 - 反应性预防的潜在效果。
PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007077. doi: 10.1371/journal.pntd.0007077. eCollection 2019 Mar.
3
Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial.单剂量口服环丙沙星预防措施应对非洲脑膜炎带的脑膜炎球菌性脑膜炎流行:一项 3 臂、开放性标签、整群随机试验。
PLoS Med. 2018 Jun 26;15(6):e1002593. doi: 10.1371/journal.pmed.1002593. eCollection 2018 Jun.
4
Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial.环丙沙星用于脑膜炎球菌性脑膜炎病例接触者的疫情应对:一项整群随机试验的研究方案
Trials. 2017 Jun 24;18(1):294. doi: 10.1186/s13063-017-2028-y.
5
Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis.职业健康最新资讯:聚焦于通过暴露前预防和暴露后预防来预防感染的获得。
Infect Dis Clin North Am. 2016 Sep;30(3):729-57. doi: 10.1016/j.idc.2016.04.008.

本文引用的文献

1
The costs associated with the public health management of a cluster of meningococcal infection in England.英格兰一起脑膜炎奈瑟菌感染聚集性公共卫生管理的费用。
Vaccine. 2014 Sep 29;32(43):5549-51. doi: 10.1016/j.vaccine.2014.08.044. Epub 2014 Aug 27.
2
Antibiotics for preventing meningococcal infections.用于预防脑膜炎球菌感染的抗生素。
Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5.
3
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].A 群脑膜炎奈瑟球菌结合疫苗(PsA-TT)对乍得 A 群脑膜炎奈瑟球菌脑膜炎和带菌的影响:一项社区研究[已更正]。
Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12.
4
Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact.引入 B 群脑膜炎奈瑟菌疾病疫苗接种:潜在影响的经济和数学建模研究。
Vaccine. 2013 May 28;31(23):2638-46. doi: 10.1016/j.vaccine.2013.03.034. Epub 2013 Apr 6.
5
Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.青少年脑膜炎球菌病的转归:前瞻性配对队列研究。
Pediatrics. 2009 Mar;123(3):e502-9. doi: 10.1542/peds.2008-0581.
6
Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.在出现一例脑膜炎球菌病病例后,除化学预防外对家庭接触者进行疫苗接种的有效性:一项系统评价
Epidemiol Infect. 2008 Nov;136(11):1441-7. doi: 10.1017/S0950268808000770. Epub 2008 Jun 18.
7
The detection of meningococcal household clusters and their prophylaxis in the changing epidemiological situation of invasive meningococcal disease in Poland, 2003-2006.2003 - 2006年波兰侵袭性脑膜炎球菌病流行病学形势变化下的脑膜炎球菌家庭聚集性病例检测及其预防措施
Euro Surveill. 2008 Mar 6;13(10):8059. doi: 10.2807/ese.13.10.08059-en.
8
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.AMSTAR的开发:一种评估系统评价方法学质量的测量工具。
BMC Med Res Methodol. 2007 Feb 15;7:10. doi: 10.1186/1471-2288-7-10.
9
Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.欧洲的脑膜炎球菌病疫苗接种:结合疫苗使用的综述与建议
FEMS Microbiol Rev. 2007 Jan;31(1):101-7. doi: 10.1111/j.1574-6976.2006.00053.x. Epub 2006 Dec 1.
10
A surveillance network for meningococcal disease in Europe.欧洲的脑膜炎球菌病监测网络。
FEMS Microbiol Rev. 2007 Jan;31(1):27-36. doi: 10.1111/j.1574-6976.2006.00060.x. Epub 2006 Dec 1.

化学预防和疫苗接种在预防脑膜炎球菌病病例家庭接触者后续脑膜炎球菌病病例中的作用:一项系统评价

Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.

作者信息

Telisinghe L, Waite T D, Gobin M, Ronveaux O, Fernandez K, Stuart J M, Scholten R J P M

机构信息

Field Epidemiology Services,Public Health England,Bristol,UK.

World Health Organization,Geneva,Switzerland.

出版信息

Epidemiol Infect. 2015 Aug;143(11):2259-68. doi: 10.1017/S0950268815000849. Epub 2015 Apr 28.

DOI:10.1017/S0950268815000849
PMID:25916733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9150978/
Abstract

Household contacts of an index case of invasive meningococcal disease (IMD) are at increased risk of acquiring disease. In revising WHO guidance on IMD in sub-Saharan Africa, a systematic review was undertaken to assess the effect of chemoprophylaxis and of vaccination in preventing subsequent cases of IMD in household contacts following an index case. A literature search for systematic reviews identified a single suitable review on chemoprophylaxis in 2004 (three studies meta-analysed). A search for primary research papers published since 2004 on chemoprophylaxis and without a date limit on vaccination was therefore undertaken. There were 2381 studies identified of which two additional studies met the inclusion criteria. The summary risk ratio for chemoprophylaxis vs. no chemoprophylaxis (four studies) in the 30-day period after a case was 0·16 [95% confidence interval (CI) 0·04-0·64, P = 0·008]; the number needed to treat to prevent one subsequent case was 200 (95% CI 111-1000). A single quasi-randomized trial assessed the role of vaccination. The risk ratio for vaccination vs. no vaccination at 30 days was 0·11 (95% CI 0·01-2·07, P = 0·14). The results support the use of chemoprophylaxis to prevent subsequent cases of IMD in household contacts of a case. Conclusions about the use of vaccination could not be drawn.

摘要

侵袭性脑膜炎球菌病(IMD)首例病例的家庭接触者感染该病的风险增加。在修订世界卫生组织关于撒哈拉以南非洲地区IMD的指南时,开展了一项系统评价,以评估化学预防和疫苗接种对预防首例病例后家庭接触者中后续IMD病例的效果。对系统评价进行的文献检索发现了2004年一项关于化学预防的合适评价(对三项研究进行了荟萃分析)。因此,对2004年以来发表的关于化学预防且对疫苗接种无时间限制的原始研究论文进行了检索。共识别出2381项研究,其中另有两项研究符合纳入标准。病例发生后30天内,化学预防与未进行化学预防(四项研究)的汇总风险比为0·16[95%置信区间(CI)0·04 - 0·64,P = 0·008];预防一例后续病例所需治疗人数为200(95%CI 111 - 1000)。一项单组半随机试验评估了疫苗接种的作用。30天时疫苗接种与未接种疫苗的风险比为0·11(95%CI 0·01 - 2·07,P = 0·14)。结果支持使用化学预防措施来预防病例家庭接触者中的后续IMD病例。关于疫苗接种使用的结论尚无法得出。